LXR agonists (Bristol-Myer Squibb)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug NameLXR agonists (Bristol-Myer Squibb)
Drug Alias Nameliver X receptors agonists (Bristol-Myers Squibb)substituted tetrahydroisoquinoline LXR agonists (Bristol-Myers Squibb)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionLiver X receptor agonists
TargetsLiver X receptor
Therapy Area/IndicationsCardiovascular Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesBristol-Myers Squibb Company
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBristol-Myers Squibb Company
Active IndicationsN/A
Inactive IndicationsCardiovascular Diseases

Other Information

ATC CodeN/A
Related LinksN/A